In March 2025, the company declared new options to get a immediate-to-buyer featuring of its Wegovy weight loss drug. The company recognized a new pharmacy, called NovoCare, which would cost clients $499 a month for entry to the drug, less than 50 % the price of the drug by other pharmaceutical